EORTC Group Phase II Study of Oral Etoposide for Pretreated Soft Tissue Sarcoma
Purpose. This study investigates the efficacy and toxicity of daily oral etoposide in chemotherapy for non-heavily pretreated advanced and metastatic soft tissue sarcoma (STS).
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hindawi Limited
1997-01-01
|
| Series: | Sarcoma |
| Online Access: | http://dx.doi.org/10.1080/13577149778371 |